| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/09/1993 | EP0545212A1 Use of glucocorticoid monoesters, especially dexamethasone-in-sulfobenzoate, for the preparation of a parenterally applicable medicament for the treatment of diseases for which glucocorticoids are indicated |
| 06/09/1993 | EP0545209A1 Redispersable dispersion powders of a copolymer of N-vinylpyrrolidone and vinyl acetate, their preparation and use |
| 06/09/1993 | EP0545194A1 Stable formulation of enalapril salt, a process for the preparation thereof and the use thereof |
| 06/09/1993 | EP0545186A2 Substrate material for smoking articles |
| 06/09/1993 | EP0544948A1 Intraocular and intraorbital implantable devices for the controlled release of pharmacological agents |
| 06/09/1993 | EP0544900A1 Transdermal nicotine absorption dosage unit and process |
| 06/09/1993 | EP0544874A1 Method for preparing submicron particles in the presence of lipid vesicles, and corresponding compositions |
| 06/09/1993 | EP0544832A1 Recombinant bpi proteins, uses of bpi proteins, and methods of preparing same |
| 06/09/1993 | EP0544671A1 COLONIC-TARGETED ORAL DRUG-DOSAGE FORMS BASED ON CROSSLINKED HYDROGELS CONTAINING AZOBONDS AND EXHIBITING pH-DEPENDENT SWELLING |
| 06/09/1993 | EP0544657A1 Method for making uniformly-sized particles from insoluble compounds |
| 06/09/1993 | EP0463061B1 Controlled release delivery device for macromolecular proteins |
| 06/09/1993 | EP0437451B1 Finely divided solid crystalline powders via precipitation into an anti-solvent |
| 06/09/1993 | EP0417075B1 Minoxidil gel |
| 06/09/1993 | DE4140194A1 Ein dihydropyridinderivat in nanosolform enthaltendes arzneimittel und seine herstellung A dihydropyridine derivative containing in nanosol drug and its manufacture |
| 06/09/1993 | DE4140192A1 Sol-gesteuerte thermokolloidmatrix auf gelatinebasis fuer perorale retardformen Sol-controlled thermo-colloid matrix based on gelatin for oral sustained-release forms |
| 06/09/1993 | DE4140191A1 Retardform fuer ein 3-indolylessigsaeurederivat enthaltendes arzneimittel und seine herstellung Release form for a 3-indolylacetic acid derivative containing drug and its manufacture |
| 06/09/1993 | DE4140186A1 Oral dosage forms for peptide drugs - esp. insulin, contg. drug in gelatin matrix |
| 06/09/1993 | DE4140185A1 Ein 2-arylpropionsaeurederivat in nanosolform enthaltendes arzneimittel und seine herstellung A 2-arylpropionic acid derivative in nanosol containing drug and its manufacture |
| 06/09/1993 | DE4140184A1 Akutform fuer ein flurbiprofen enthaltendes arzneimittel und seine herstellung Acute form for a drug-containing flurbiprofen and its manufacture |
| 06/09/1993 | DE4140179A1 Akutform fuer ein ibuprofen enthaltendes arzneimittel und seine herstellung Acute form for an ibuprofen-containing drug and its manufacture |
| 06/09/1993 | DE4140178A1 Oral administration forms for peptidic medicaments |
| 06/09/1993 | DE4140177A1 Oral administration forms for peptidic medicaments |
| 06/09/1993 | DE4140116A1 Dimeticon-pastillen Dimethicone pastilles |
| 06/09/1993 | CN1072863A Enhandced skin penetration system for improved topical delivery of drugs |
| 06/09/1993 | CN1072861A A carbohydrate glass matrix for the sustained release of a therapeutic agent |
| 06/09/1993 | CN1072843A Gel-type cosmetic composite |
| 06/08/1993 | US5218113 N-substituted thiolactams |
| 06/08/1993 | US5218096 Sweet, stable, nontoxic polysaccharide from treatment of mixture of lactose and starch or derivative with transferase enzyme |
| 06/08/1993 | US5218039 Pan emulsion |
| 06/08/1993 | US5217965 Stabilized solid dosage forms of choline metal carboxymethylcellulose salicylate compositions |
| 06/08/1993 | US5217951 Treatment of inflammation |
| 06/08/1993 | US5217720 Coated solid medicament form having releasability in large intestine |
| 06/08/1993 | US5217719 Surface-treated sodium bicarbonate particle and molded preparation thereof |
| 06/08/1993 | US5217718 Using pressure sensitive adhesive skin patch |
| 06/08/1993 | US5217712 Bioerodible thermoset elastomers |
| 06/08/1993 | US5217707 Pharmaceutical composition and process for the preparation thereof |
| 06/08/1993 | US5217648 In physiologically compatible oil |
| 06/08/1993 | US5217449 Medical capsule and apparatus for activating the same |
| 06/08/1993 | CA1318825C Plurality of tiny pills in liquid dosage form |
| 06/08/1993 | CA1318822C Wound dressing |
| 06/05/1993 | CA2084432A1 Contrast agents for ultrasound imaging |
| 06/03/1993 | DE4139883A1 Prodn. of bio-adhesive medicament, e.g. oral or vaginal tablet - comprises mixing drug with swellable, bio-adhesive polymer, dispersant and opt. binder |
| 06/03/1993 | DE4139118A1 Slow-release micro-tablets contg. dry extract of vegetable origin - e.g. gingkolide B or aesculus extract and glyceride, fatty alcohol and/or wax as lipophilic auxiliary |
| 06/02/1993 | EP0544612A2 Composition comprising an immunogen and a triglyceride |
| 06/02/1993 | EP0544450A1 Supported Microspheres |
| 06/02/1993 | EP0544144A1 Solid pharmaceutical retard form |
| 06/02/1993 | EP0544097A1 Semi-solid mixtures of oligomers and/or polymers based on lactic acid, process for their preparation and their use as resorbable implants |
| 06/02/1993 | EP0543943A1 Mixed lipid-bicarbonate colloidal particles for delivering drugs or calories. |
| 06/02/1993 | EP0543871A1 Stable doxorubicin/liposome composition |
| 06/02/1993 | EP0543868A1 Dressing system. |
| 06/02/1993 | EP0543811A1 Topical treatment of blepharitis |
| 06/02/1993 | EP0528834A4 Enzymatic synthesis of soluble phosphatides from phospholipids |
| 06/02/1993 | CN1072602A Enhanced skin penetration system for improved topical delivery of drugs |
| 06/02/1993 | CN1072598A Preparing method for compound drynaria rhizome sucked pill |
| 06/02/1993 | CN1072595A Production method of burn and scald gel |
| 06/02/1993 | CN1072593A Emulsions containing alkyl-or alkylglycerophosphoryl choline surfactants and methods of use |
| 06/02/1993 | CN1072592A Preparation method of artificial mucus for lubricting body cavity |
| 06/02/1993 | CN1072576A Substrate material for smoking articles |
| 06/01/1993 | US5216115 Polyarylate containing derivatives of the natural amino acid L-tyrosine |
| 06/01/1993 | US5216011 Solvent mixture consisting of propylene glycol and water |
| 06/01/1993 | US5216001 Central nervous system disorders |
| 06/01/1993 | US5215965 Treatment of inflammation |
| 06/01/1993 | US5215758 Controlled release matrix suppository for pharmaceuticals |
| 06/01/1993 | US5215757 Encapsulated materials |
| 06/01/1993 | US5215756 Preparation of pharmaceutical and other matrix systems by solid-state dissolution |
| 06/01/1993 | US5215755 Povidone binder, sodium starch glycolate, sodium lauryl sulfate, drug and hydroxyalkyl cellulose coating |
| 06/01/1993 | US5215754 Comprising calcium polycarbophil, crosslinked polyvinypyrrolidone and polyvinypyrrolidone swelling, in intestines, gas-free |
| 06/01/1993 | US5215753 Including viscosity-increasing amount of inert agent; pressure-inducing exit member; administering at controlled rate over time |
| 06/01/1993 | US5215752 Pharmaceutical tablets and capsule granulates of scleroglucan and active substance |
| 06/01/1993 | US5215751 Therapeutic system for the retarded and controlled transdermal or transmucous administration of active substances (i) |
| 06/01/1993 | US5215743 Tumor necrosis factor formulations |
| 06/01/1993 | US5215739 Spray gel base and spray gel preparation using thereof |
| 06/01/1993 | US5215738 Benzamide and nicotinamide radiosensitizers |
| 06/01/1993 | US5215680 Method for the production of medical-grade lipid-coated microbubbles, paramagnetic labeling of such microbubbles and therapeutic uses of microbubbles |
| 06/01/1993 | CA1318602C Controlled release combination of carbidopa/levodopa |
| 06/01/1993 | CA1318600C Sustained release etodolac |
| 06/01/1993 | CA1318599C Pharmaceutical compositions containing dyclonine hc1 and phenol |
| 06/01/1993 | CA1318598C Transdermal formulation containing 3-isobutyryl-2-isopropylpyrazolo [1,5-a] pyridine |
| 06/01/1993 | CA1318597C Inhalant containing 3-isobutyryl-2-isopropylpyrazolo [1,5-a] pyridine |
| 06/01/1993 | CA1318589C Drug delivery system |
| 06/01/1993 | CA1318587C Sustained release growth hormone compositions for parenteral administration and their use |
| 06/01/1993 | CA1318543C Sorbitol coated comestible and method of preparation |
| 06/01/1993 | CA1318482C Granular product (i) |
| 05/29/1993 | CA2067519A1 Use of glucocorticoid compounds for the production of compositions for the treatment of disorders in which glucocorticoids are indicated |
| 05/28/1993 | WO1993010765A1 Controlled release oxycodone compositions |
| 05/28/1993 | CA2083232A1 Fibronectin-containing ophthalmic solution, method of manufacture of an ophthalmic solution, method of preserving an ophthalmic solution, and methods of treatment of ophthalmic wounds |
| 05/27/1993 | WO1993010440A1 Gel particle contrast media for improved diagnostic imaging |
| 05/27/1993 | WO1993010201A1 Pressure-sensitive poly(n-vinyl lactam) adhesive composition and method for producing and using same |
| 05/27/1993 | WO1993010163A2 Adhesive hydrogels having extended use lives and process for the preparation of same |
| 05/27/1993 | WO1993010131A1 Benzoate esters of alkoxylated methyl glucosides |
| 05/27/1993 | WO1993009833A1 Method and apparatus for partial liquid ventilation using fluorocarbons |
| 05/27/1993 | WO1993009820A1 System employing a sterile medical solution containing glucose or glucose-like compounds and a solution intended for said system |
| 05/27/1993 | WO1993009805A1 Polar lipid composition of plant origin |
| 05/27/1993 | WO1993009793A1 Lactobacillus and skim milk compositions and methods for preventing microbial urogenital infections |
| 05/27/1993 | WO1993009787A1 Emulsions containing alkyl- or alkylgylcerophosphoryl choline surfactants and methods of use |
| 05/27/1993 | WO1993009785A1 Risedronate delayed-release compositions |
| 05/27/1993 | WO1993009784A1 Unit dose form of bismuth subsalicylate |
| 05/27/1993 | WO1993009781A1 Sustained-release trapidil tablet |
| 05/27/1993 | WO1993009775A1 Unbuffered premixed ranitidine formulation |
| 05/27/1993 | WO1993009771A1 Controlled release flutamide composition |